Effects of Sexual Rehabilitation on Sexual Dysfunction in Patients with Cardiovascular Disease: A Systematic Review

Jae Joon Park1, Seung Whan Doo1, Allison Kwon2

  • 1Department of Urology, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea.

Insights

Sexual rehabilitation significantly improves sexual dysfunction in cardiovascular disease (CVD) patients. This approach offers high therapeutic potential, addressing a common issue affecting up to 89% of CVD patients.

Area of Science:

  • Cardiology
  • Sexual Medicine
  • Rehabilitation Medicine

Background:

  • Cardiovascular disease (CVD) is a leading cause of mortality globally.
  • Sexual dysfunction affects up to 89% of CVD patients, often due to physical/mental changes or medication side effects.
  • Conventional treatments like pharmacotherapy show limited efficacy for sexual problems in CVD patients.

Purpose of the Study:

  • To systematically review and meta-analyze the effectiveness of sexual rehabilitation interventions for sexual dysfunction in patients with cardiovascular disease (CVD).

Main Methods:

  • Comprehensive literature searches were performed across major databases (MEDLINE, Cochrane Library, EMBASE) up to June 2022.
  • Standardized Mean Difference (SMD) with 95% Confidence Intervals (CIs) were calculated for questionnaire scores.
  • Risk of bias assessment was conducted using the RoB 2 tool, and meta-regression analysis was applied.

Main Results:

  • Sexual rehabilitation demonstrated a significant overall positive effect (SMD = 0.430, 95% CI: 0.226-0.633) compared to no intervention.
  • Improvements were noted at one month (SMD = 0.674) and six months (SMD = 0.320).
  • Meta-regression analysis did not reveal significant effects of patient numbers, study duration, or questionnaire types.

Conclusions:

  • Sexual rehabilitation is an effective strategy with considerable therapeutic potential for managing sexual dysfunction in cardiovascular disease (CVD) patients.
  • Further well-designed, large-scale studies are needed to support clinical application.
  • Standardization of sexual rehabilitation protocols is recommended for future research and practice.
Abstract

Related Concept Videos

Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
418
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
481
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
18
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors01:28

Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors

Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
224
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
1.0K
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
22